Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

’Disappearing’ tumour study could lead to new cancer treatments

04.06.2003


A research study at The University of Nottingham looking at how growth can contribute to spontaneous childhood cancer regression could lead to more effective ways of treating tumours.



The one-year project, led by Christopher Jones in the School of Nursing in collaboration with Dr Michael Symonds in the Division of Child Health and Dr David Walker at the University’s Children’s Brain Tumour Research Centre, will look at whether growth hormone plays a part in tumours spontaneously getting better.

The researchers are looking at neuroblastoma, which accounts for around six per cent of all childhood cancers. Around 100 children develop neuroblastoma each year in the UK and most of these are less than four years of age.


In around three-quarters of these cases the cancer spreads around the body and the current survival rates are only around 30 per cent.

However, when a tumour of this kind occurs in the liver, particularly in the first year of life, it is only fatal in between 10 and 20 per cent of sufferers and, in many cases, spontaneously regresses without the need for treatment.

Scientists have been studying this medical phenomenon for many years, although most research has centred on looking at the biology of the tumour in an effort to discover why it self-destructs.

The Nottingham researchers, however, believe it could be something within the body and not the tumour itself that sparks off this regression and think that it could be due to the release of hormones that control growth in infancy.

Dr Michael Symonds said: "We believe that spontaneous tumour regression is linked to unique changes within the liver in early childhood, which coincide with the onset of growth hormone-dependent growth."

It is hoped that the study, funded with £7,000 from the Special Trustees of Nottingham University Hospital, will attract more funding for the study of childhood cancers and could even lead to more effective treatments for non-regressing neuroblastoma, as well as other aggressive tumours such as breast cancer and certain types of childhood brain tumours.

Lyn Heath-Harvey | alfa
Further information:
http://www.nottingham.ac.uk/public-affairs/index.html

More articles from Health and Medicine:

nachricht Chances to treat childhood dementia
24.07.2017 | Julius-Maximilians-Universität Würzburg

nachricht World first: Massive thrombosis removed during early pregnancy
20.07.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

Ultrathin device harvests electricity from human motion

24.07.2017 | Power and Electrical Engineering

Scientists announce the quest for high-index materials

24.07.2017 | Materials Sciences

ADIR Project: Lasers Recover Valuable Materials

24.07.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>